FDA Clearance Tracker · K261409
BioTeke® Multi-Drug Urine Test Cup
Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 10, 2026
Substantially Equivalent
Time to decision
133 days
Received Apr 30, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K261409
- Device name
- BioTeke® Multi-Drug Urine Test Cup
- Applicant
- Bioteke Corporation (Wuxi) Co., Ltd.
- Applicant location
- Wuxi, CN
- Received
- Apr 30, 2026
- Decided
- Sep 10, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Amphetamine, Over The Counter (NFT)
- Device class
- Class II
- Regulation
- 21 CFR 862.3100
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NFT. The earliest in FDA's data is K170049, decided May 2, 2017.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K261409
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bioteke Corporation (Wuxi) Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K211707 · Decided May 4, 2022 · 335 days after receipt
Device type: Culture Media, Non-Propagating Transport (JSM) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.